Blog

For most retired workers, Social Security is more than just a monthly deposit into their checking or savings account. It represents a pillar that, in many instances, is necessary to support their

Saving for retirement is very different from saving for other goals, like a home or car. If you're looking to buy a house in a neighborhood where the average home price is $500,000, and you want to

At any given time, there are one or more significant market headwinds threatening to drive the benchmark S&P 500 (SNPINDEX: ^GSPC), iconic Dow Jones Industrial Average (DJINDICES: ^DJI), and

Earnings season is in full swing, and some of the most closely watched companies have given investors crucial information to chew on. On July 31, Amazon (NASDAQ: AMZN) reported earnings for the

In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:

To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When

A beat-and-raise fiscal third quarter was the fuel driving Blue Bird (NASDAQ: BLBD) stock forward this week. Thanks mostly to this the company's shares motored over 27% higher during the period

A lot can happen in 15 years. Kids grow up. Technologies are replaced. Jobs and addresses change. Even seemingly entrenched corporations are dethroned as market leaders.

And it's this last

What's the key to achieving financial freedom? And what's the real risk investors face?

In this podcast, Motley Fool analyst Buck Hartzell and contributor Rich Lumelleau talk with financial theorist

Shares of Gartner (NYSE: IT) cratered this week, finishing down 30.3% from last Friday's close. The drop came as the S&P 500 and Nasdaq-100 gained 2.4% and 3.7%, respectively.

Gartner, an IT- and

Pelton (NASDAQ: PTON) stock closed out Friday's trading session with big gains. The company's share price gained 10.3% on the day's trading and had been up as much as 11.5% earlier in the session.

Investors are typically quite harsh on publicly traded companies that don't make their quarterly estimates, a dynamic vividly on display Friday with biotech stock Iovance Biotherapeutics (NASDAQ:

Shares of Rocket Lab (NASDAQ: RKLB) opened Friday's trading with big gains, but it ended the daily session only modestly in the green. The space-tech company's share price rose 1% in today's

On Friday, the stock of Novo Nordisk (NYSE: NVO) continued to be affected by results from the lab the previous day. The interesting twist: It wasn't the company conducting the research.

Rather, it

Explore the exciting world of DoorDash (NASDAQ: DASH) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Plains GP Holdings(NASDAQ:PAGP) reported second-quarter 2025 adjusted EBITDA of $672 million and announced a $3.75 billion divestiture of its NGL business to Keyera, with closing expected in 2026

The stock of Tempus AI (NASDAQ: TEM) gave back some of its gains after surging early in Friday's trading, but it still ended the daily session solidly in the green. The healthcare artificial

Plains All American Pipeline (NASDAQ:PAA) reported adjusted EBITDA of $672 million for Q2 2025 and reaffirmed its full-year 2025 EBITDA guidance of $2.8 billion to $2.95 billion. The company

Essent Group(NYSE:ESNT) reported second-quarter 2025 results on Aug. 8, 2025, with GAAP net income of $195 million, diluted EPS of $1.93, and annualized return on average equity of 14%. Insurance in

Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterly earnings after the stock market's close on Thursday, and the investor reaction was strong the following day. Happily for

Shares of SoundHound AI (NASDAQ: SOUN) posted explosive gains in Friday's trading. The conversational and agentic artificial intelligence (AI) specialist's stock closed out the daily session up

The stock of digital advertising analysis company Integral Ad Science (NASDAQ: IAS) enjoyed a double-digit jump on Friday. The shares rose a hearty 12%-plus following the release of second-quarter

Shares of Eli Lilly (NYSE: LLY) sank 18% this week, according to data from S&P Global Market Intelligence. The drugmaker with a market cap of over $500 billion is in a sharp drawdown due to

Femasys (NASDAQ:FEMY), a women’s health medical technology firm developing permanent birth control and fertility solutions, released its second quarter 2025 results on August 8, 2025. The earnings

Surrozen (NASDAQ:SRZN), a biotechnology company focused on Wnt pathway modulation in regenerative medicine, delivered its second quarter 2025 earnings on August 8, 2025. The most notable headline

Solana's (CRYPTO: SOL) price has climbed by around 15% since late April, moving from about $146 to roughly $167 as I write this.

The move is hardly breathtaking. Still, it prompts a pair of bigger